Medi Assist Healthcare Services Ltd Stock Hits 52-Week Low at Rs.352.2

Stock Price Movement and Volatility

On 2 March 2026, Medi Assist Healthcare Services Ltd opened with a gap up of 9.03%, reaching an intraday high of Rs.403.95. However, the stock reversed course sharply, hitting an intraday low of Rs.352.2, which represents the new 52-week and all-time low. This intraday volatility was notably high at 12.72%, calculated from the weighted average price, indicating significant price swings within the trading session. Despite the initial positive momentum, the stock closed with a day change of -4.06%, underperforming its sector, which declined by 2.99% on the same day.

The stock currently trades below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a sustained bearish trend. This technical positioning underscores the challenges the stock faces in regaining upward momentum in the near term.

Comparative Market Context

While the broader market, represented by the Sensex, experienced a volatile session—opening sharply lower by 2,743.46 points before recovering 1,173.18 points to trade at 79,716.91 (down 1.93%)—Medi Assist’s performance lagged behind both the market and its sector peers. The Sensex remains below its 50-day moving average, although the 50DMA is positioned above the 200DMA, suggesting mixed signals for the broader market trend.

Over the past year, Medi Assist Healthcare Services Ltd has delivered a negative return of -21.52%, contrasting with the Sensex’s positive 8.87% gain over the same period. The stock’s 52-week high was Rs.594.4, highlighting the extent of the decline from its peak.

Financial Performance and Valuation Metrics

The company’s recent quarterly results have contributed to the subdued market sentiment. Profit Before Tax (PBT) for the quarter stood at Rs.15.11 crore, reflecting a decline of 23.9% compared to the average of the previous four quarters. Net Profit After Tax (PAT) also fell sharply by 45.4% to Rs.11.11 crore in the same period. Additionally, interest expenses reached a quarterly high of Rs.8.39 crore, adding to the financial pressures.

Despite these setbacks, Medi Assist maintains a Return on Equity (ROE) of 14.05%, which indicates a degree of long-term fundamental strength. However, the stock’s valuation appears expensive relative to its book value, trading at a Price to Book (P/B) ratio of 4.8. This valuation is at a discount compared to the average historical valuations of its peers, reflecting the market’s cautious stance.

Long-Term and Recent Performance Trends

Over the last three years, Medi Assist has underperformed the BSE500 index across multiple time frames, including the one-year and three-month periods. The stock’s negative return of -21.52% over the past year contrasts with a modest 5% increase in profits during the same timeframe, highlighting a disconnect between earnings growth and market valuation.

The stock’s recent downward trajectory, including the eight consecutive days of decline, has intensified concerns about its near-term prospects. The cumulative loss of 14.35% over these eight sessions underscores the persistent selling pressure.

Sector and Market Capitalisation Considerations

Medi Assist operates within the insurance industry, specifically classified under the miscellaneous sector, which has seen a decline of 2.99% on the day of the stock’s new low. The company’s market capitalisation grade is rated at 3, reflecting a mid-tier valuation relative to its peers. The Mojo Score assigned to the stock is 23.0, with a Mojo Grade of Strong Sell as of 2 December 2025, an upgrade from the previous Sell rating. This grading reflects the stock’s deteriorated financial metrics and price performance.

The stock’s performance today, with a day change of -4.06%, further emphasises its underperformance relative to the sector and broader market indices. The gap up opening followed by a sharp decline within the same session illustrates the volatility and uncertainty surrounding the stock.

Summary of Key Metrics

To summarise, Medi Assist Healthcare Services Ltd’s stock has reached a new 52-week low of Rs.352.2, following a sustained period of decline marked by eight consecutive losing sessions and a total loss of 14.35% during this stretch. The company’s recent quarterly results have shown declines in profitability and increased interest expenses, contributing to the cautious market sentiment. Despite a solid ROE of 14.05%, the stock’s valuation remains elevated on a price-to-book basis, and it continues to trade below all major moving averages.

The broader market context, including the Sensex’s partial recovery after a sharp fall, contrasts with the stock’s continued weakness. Medi Assist’s underperformance relative to the Sensex and its sector peers over the past year and longer periods highlights the challenges it faces in regaining investor confidence.

Investors and market participants will be closely monitoring the stock’s price action and financial disclosures in the coming sessions to assess any shifts in trend or valuation.

Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →